- Home
- » Tags
- » Tocilizumab
Top View
- Immunosuppressive Drugs and COVID-19: a Review
- INN Working Document 05.179 Update 2011
- Codes Drug Name J3262 Actemra (Tocilizumab) IV Only C9399, A4641
- A Review on the Effect of COVID-19 in Type 2 Asthma and Its Management
- Immunomodulators
- (INN) for Biological and Biotechnological Substances
- Anti-IL6R: Tocilizumab, Satralizumab, Sarilumab, Olokizumab, Vobarilizumab Anti-IL6: Siltuximab, Sirukumab, Clazakizumab
- Rxoutlook® 3Rd Quarter 2020
- Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
- WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
- WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
- (12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
- Tocilizumab Intravenous – (M0004)
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Financial and Non-Financial Highlights Chugai Pharmaceutical Co., Ltd
- PRODUCT MONOGRAPH Practemra
- International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
- Specialty Pipeline: March 2021
- Datasheet: HCA252 Product Details
- VACCINE GUIDELINES for IMMUNOCOMPROMISED and OTHER SPECIAL POPULATIONS I. GENERAL PRINCIPLES COVID-19 Immunization Is Recommen
- Use of Monoclonal Antibody Products to Treat COVID-19 in Washington State
- Report on the Deliberation Results August 10, 2017 Pharmaceutical
- Review Article Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions
- Australian Public Assessment Report for Tocilizumab
- COVID-19 Immune Modulation Domain Specific Appendix
- Supplementary Information
- Management of Steroid Resistant Acute and Chronic GVHD: Are We Making Progress?
- Immunology; an Illustrated Outline; Sixth Edition
- FACT SHEET for HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION for ACTEMRA® (Tocilizumab)
- Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab, Tocilizumab and Abatacept for Rheumatoid Arthritis Not Previously Treated with Dmards Or Aft
- Tocilizumab Fact Sheet for Patients
- Anti-Il6-R Tocilizumab in Refractory and Non-Infectious Uveitic Cystoid Macular Edema
- Hypersensitivity Reactions to Biological Drugs M Corominas,1 G Gastaminza,2 T Lobera3
- Drug Effectiveness Review Project Summary Report – Biologics (Targeted Immune Modulators)
- Previously Reported Placebo-Response-Associated Variants Do Not Predict Patient Outcomes in Inflammatory Disease Phase III Trial
- Roche's Lebrikizumab Phase Iib Data Show Reduction of Asthma Attack Rates and Improvement of Lung Function in Adult Patients W
- Tocilizumab), Human Igg1 Antibody
- Roche to Present New Data on Medicines for Autoimmune Diseases and Severe Inflammatory Disorders at the 2016 ACR/ARHP Annual
- Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-Mediated Rejection in Kidney Transplant Recipients
- 4CPS-314 3 Day Course of Low Dose Subcutaneous Anakinra in Patients with Refractory Moderate–Severe COVID-19: a Proof-Of-Concept Study
- Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
- 2020 Table of Drugs
- Download ACTEMRA Prescribing Information
- Infliximab Combination for the Treatment of Severe Gastrointestinal Acute Gvhd
- Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
- Fecal Microbiota Potentiate Checkpoint Inhibitors, Unleash Microbiome
- Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
- Tocilizumab) in Neuromyelitis Optica and NMO Spectrum Disorders
- (INN) for Biological and Biotechnological Substances
- Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
- Do Not Tube List
- Thalidomide - Wikipedia, the Free Encyclopedia
- Cimzia® (Certolizumab Pegol) – Oxford Clinical Policy
- Mediated Rejection; Histological Improvement, Reduction of Proteinuria and Renal Function Stabilization
- Use of Tocilizumab for Covid-19 in Hospitalised Adults Drug Guideline
- Adalimumab, Etanercept, Infliximab
- Kidney Transplantation and COVID-19
- The Use of Intravenous Versus Subcutaneous Monoclonal
- Roactemra, INN-Tocilizumab
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- COVID-19: an Immunological Perspective
- Ocular Side Effects of Antirheumatic Medications: a Qualitative Review
- Tocilizumab Reduces Deaths in Patients Hospitalised with COVID-19